Authors/Disclosures
|
Jose R. Romero, MD
(Boston University School of Medicine - Boston Medical Center)
|
The institution of Dr. Romero has received research support from NIH/NIA. |
|
Lila E. Sheikhi, MD
(Hawthorn Health, LLC)
|
Dr. Sheikhi has nothing to disclose. |
|
Christopher T. Primiani, MD
|
Dr. Primiani has nothing to disclose. |
|
Sudha Seshadri, MD, FAAN
(Glenn Biggs Institute for Alzheimer'S and Neurodegenerative Diseases)
|
Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Seshadri has received research support from NIH. The institution of Dr. Seshadri has received research support from Alzheimer Association. |
|
Randhi V. Narayana, MD, FAAN
|
Dr. Narayana has nothing to disclose. |
|
|
No disclosure on file |
|
Alexa Beiser
|
Alexa Beiser has nothing to disclose. |
|
Italo Linfante, MD
(Miami Cardiac And Vascular Institute, Baptist Hospital and Neuroscience Center)
|
Dr. Linfante has received personal compensation for serving as an employee of medtronic. Dr. Linfante has received personal compensation for serving as an employee of stryker. Dr. Linfante has received personal compensation for serving as an employee of cerenovus. Dr. Linfante has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for medtronic. Dr. Linfante has received stock or an ownership interest from InNeuroCO. Dr. Linfante has received stock or an ownership interest from Stryker/Surpass. |
|
Charles S. DeCarli, MD, FAAN
(UC Davis Health - Dept of NeurologyAlzheimer's Disease Research Center)
|
Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. DeCarli has received research support from NIH. |
|
Rhoda Au, PhD
(Boston University School of Medicine)
|
Dr. Au has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Au has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Au has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Au has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NovoNordisk. Dr. Au has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. Dr. Au has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Au has received publishing royalties from a publication relating to health care. Dr. Au has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with Davos Alzheimer's Collaborative. Dr. Au has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with High Lantern. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Philip A. Wolf, MD, FAAN
|
No disclosure on file |